Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 3
2005 4
2006 5
2007 3
2008 4
2009 17
2010 25
2011 34
2012 21
2013 17
2014 20
2015 14
2016 31
2017 31
2018 18
2019 13
2020 16
2021 28
2022 19
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Manabe M, Tsuboi R, Itami S, Osada SI, Amoh Y, Ito T, Inui S, Ueki R, Ohyama M, Kurata S, Kono T, Saito N, Sato A, Shimomura Y, Nakamura M, Narusawa H, Yamazaki M; Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss. Manabe M, et al. Among authors: nakamura m. J Dermatol. 2018 Sep;45(9):1031-1043. doi: 10.1111/1346-8138.14470. Epub 2018 Jun 4. J Dermatol. 2018. PMID: 29863806
Maresin-1 and Inflammatory Disease.
Saito-Sasaki N, Sawada Y, Nakamura M. Saito-Sasaki N, et al. Among authors: nakamura m. Int J Mol Sci. 2022 Jan 25;23(3):1367. doi: 10.3390/ijms23031367. Int J Mol Sci. 2022. PMID: 35163291 Free PMC article. Review.
Angioedema and Fatty Acids.
Wada A, Sawada Y, Sugino H, Nakamura M. Wada A, et al. Among authors: nakamura m. Int J Mol Sci. 2021 Aug 20;22(16):9000. doi: 10.3390/ijms22169000. Int J Mol Sci. 2021. PMID: 34445711 Free PMC article. Review.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Powles T, van der Heijden MS, Castellano D, Galsky MD, Loriot Y, Petrylak DP, Ogawa O, Park SH, Lee JL, De Giorgi U, Bögemann M, Bamias A, Eigl BJ, Gurney H, Mukherjee SD, Fradet Y, Skoneczna I, Tsiatas M, Novikov A, Suárez C, Fay AP, Duran I, Necchi A, Wildsmith S, He P, Angra N, Gupta AK, Levin W, Bellmunt J; DANUBE study investigators. Powles T, et al. Lancet Oncol. 2020 Dec;21(12):1574-1588. doi: 10.1016/S1470-2045(20)30541-6. Epub 2020 Sep 21. Lancet Oncol. 2020. PMID: 32971005 Clinical Trial.
STING Signaling and Skin Cancers.
Sato S, Sawada Y, Nakamura M. Sato S, et al. Among authors: nakamura m. Cancers (Basel). 2021 Nov 9;13(22):5603. doi: 10.3390/cancers13225603. Cancers (Basel). 2021. PMID: 34830754 Free PMC article. Review.
Daily Lifestyle and Cutaneous Malignancies.
Sawada Y, Nakamura M. Sawada Y, et al. Among authors: nakamura m. Int J Mol Sci. 2021 May 14;22(10):5227. doi: 10.3390/ijms22105227. Int J Mol Sci. 2021. PMID: 34069297 Free PMC article. Review.
Climber's knuckle excoriation.
Ohmori S, Sawada Y, Nakamura M. Ohmori S, et al. Among authors: nakamura m. J Dermatol. 2018 Sep;45(9):e264-e265. doi: 10.1111/1346-8138.14301. Epub 2018 Mar 23. J Dermatol. 2018. PMID: 29572907 No abstract available.
298 results